[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

WO2002074333A3 - Mycobacterial extracts used for treating allergy - Google Patents

Mycobacterial extracts used for treating allergy Download PDF

Info

Publication number
WO2002074333A3
WO2002074333A3 PCT/GB2002/001297 GB0201297W WO02074333A3 WO 2002074333 A3 WO2002074333 A3 WO 2002074333A3 GB 0201297 W GB0201297 W GB 0201297W WO 02074333 A3 WO02074333 A3 WO 02074333A3
Authority
WO
WIPO (PCT)
Prior art keywords
extracts used
mycobacterial extracts
treating allergy
allergy
mycobacterial
Prior art date
Application number
PCT/GB2002/001297
Other languages
French (fr)
Other versions
WO2002074333A2 (en
Inventor
Graham Arthur William Rook
Laura Cristina Rosa Brunet
Original Assignee
Stanford Rook Ltd
Graham Arthur William Rook
Laura Cristina Rosa Brunet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stanford Rook Ltd, Graham Arthur William Rook, Laura Cristina Rosa Brunet filed Critical Stanford Rook Ltd
Priority to AU2002241135A priority Critical patent/AU2002241135A1/en
Publication of WO2002074333A2 publication Critical patent/WO2002074333A2/en
Publication of WO2002074333A3 publication Critical patent/WO2002074333A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55588—Adjuvants of undefined constitution
    • A61K2039/55594—Adjuvants of undefined constitution from bacteria

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

The present invention relates to mycobacterial extracts comprising lipids, glycolipids and/or carbohydrates and their use in the treatment of allergy.
PCT/GB2002/001297 2001-03-20 2002-03-20 Mycobacterial extracts used for treating allergy WO2002074333A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2002241135A AU2002241135A1 (en) 2001-03-20 2002-03-20 Mycobacterial extracts used for treating allergy

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0106986.3 2001-03-20
GBGB0106986.3A GB0106986D0 (en) 2001-03-20 2001-03-20 Immunotherapeutic agent

Publications (2)

Publication Number Publication Date
WO2002074333A2 WO2002074333A2 (en) 2002-09-26
WO2002074333A3 true WO2002074333A3 (en) 2003-12-31

Family

ID=9911182

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB2002/001297 WO2002074333A2 (en) 2001-03-20 2002-03-20 Mycobacterial extracts used for treating allergy

Country Status (3)

Country Link
AU (1) AU2002241135A1 (en)
GB (1) GB0106986D0 (en)
WO (1) WO2002074333A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100992646B1 (en) * 2003-07-09 2010-11-05 제이에스알 가부시끼가이샤 Wavelength plate

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4716038A (en) * 1984-04-27 1987-12-29 Stanford John L Methods for the alleviation or treatment of arthritic disease
EP0763361A2 (en) * 1992-02-21 1997-03-19 University College London Mycobacterium vaccae for treatment of long term autoimmune conditions
WO1998039025A2 (en) * 1997-03-03 1998-09-11 Adcock Ingram Limited A composition comprising a carrier and a purified mycobacterial lipid cell-wall component and its use in the prevention, treatment and diagnosis of disease
WO1998043655A1 (en) * 1997-04-02 1998-10-08 Bioniche Inc. Use of bacterial cell wall extracts for treating topical disorders and wounds

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4716038A (en) * 1984-04-27 1987-12-29 Stanford John L Methods for the alleviation or treatment of arthritic disease
EP0763361A2 (en) * 1992-02-21 1997-03-19 University College London Mycobacterium vaccae for treatment of long term autoimmune conditions
WO1998039025A2 (en) * 1997-03-03 1998-09-11 Adcock Ingram Limited A composition comprising a carrier and a purified mycobacterial lipid cell-wall component and its use in the prevention, treatment and diagnosis of disease
WO1998043655A1 (en) * 1997-04-02 1998-10-08 Bioniche Inc. Use of bacterial cell wall extracts for treating topical disorders and wounds

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
BARROW WILLIAM W: "Processing of mycobacterial lipids and effects on host responsiveness.", FRONTIERS IN BIOSCIENCE (ONLINE), vol. 2, no. CITED SEPT. 12, 1997, 1997, pages D387 - 400, XP002235435 *
MOURA A C N ET AL: "LIPIDS FROM MYCOBACTERIUM LEPRAE CELL WALL SUPPRESS T-CELL ACTIVATION IN VIVO AND IN VITRO", IMMUNOLOGY, BLACKWELL SCIENTIFIC PUBLICATIONS, GB, vol. 92, no. 4, December 1997 (1997-12-01), pages 429 - 436, XP008014879, ISSN: 0019-2805 *
RIEDEL D D ET AL: "Differential tolerance induction by lipoarabinomannan and lipopolysaccharide in human macrophages.", MICROBES AND INFECTION / INSTITUT PASTEUR. FRANCE APR 2000, vol. 2, no. 5, April 2000 (2000-04-01), pages 463 - 471, XP002235436, ISSN: 1286-4579 *
WALKER C ET AL: "New trends in immunotherapy to prevent atopic diseases.", TRENDS IN PHARMACOLOGICAL SCIENCES. ENGLAND FEB 2001, vol. 22, no. 2, February 2001 (2001-02-01), pages 84 - 90, XP002235540, ISSN: 0165-6147 *

Also Published As

Publication number Publication date
AU2002241135A1 (en) 2002-10-03
GB0106986D0 (en) 2001-05-09
WO2002074333A2 (en) 2002-09-26

Similar Documents

Publication Publication Date Title
WO2002020002A3 (en) A method for treating allergies
WO2003032916A3 (en) Organosulfur inhibitors of tyrosine phosphatases
PL373302A1 (en) Methods and pharmaceutical compositions for immune deception, particularly useful in the treatment of cancer
WO2003057134A8 (en) Specific binding agents of human angiopoietin-2
WO2004069156A3 (en) Inactivated probiotic bacteria and methods of use thereof
AU2002367979A8 (en) Devices, systems and methods for reducing levels of pro-inflammartory or anti-inflammatrory stimulators or mediators in blood products
AUPR839001A0 (en) Dosage form, device and methods of treatment
DE60208129D1 (en) Terminal contact, connector equipped therewith and method of making the terminal contact
MXPA03009300A (en) Pant-type absorbent articles, and methods of making such absorbent articles.
AU2002345255A1 (en) Composition comprising soy and use thereof in the prevention and/or treatment of various diseases
PT1228028E (en) HYDROXYETHYETHETRAENIATE, COMPOSITIONS AND METHODS USED FOR USE IN THE TREATMENT OF OCTURAL SECURA PERTURBACOES
WO2007028151A3 (en) Surgical devices and related methods thereof
AU2002363973A8 (en) Devices, systems, and methods for reducing levels of pro-inflammatory or anti-inflammatory stimulators or mediators in the blood
WO2002102340A3 (en) Use of carnitine and/or one or more acyl-carnitines for producing cosmetic or dermatological preparations
FR2831442B1 (en) COSMETIC COMPOSITION MIMING THE SEBUM, AND USES THEREOF
WO2002074333A3 (en) Mycobacterial extracts used for treating allergy
NO20032597L (en) Use of SARP-1 for the treatment and / or prevention of scleroderma
WO2002074330A3 (en) Mycobacterrial estracts for treating autoimmune diseases
CA2530660A1 (en) Combinations of vasoprotective agents and formulations containing them
WO2002066492A3 (en) Human adrenomedullin-specific antibody, pharmaceutical composition containing same, therapeutic uses thereof
WO2002024223A3 (en) Prevention and treatment of streptococcal and staphylococcal infection
IL150527A0 (en) Use of vitamin d-derivatives in the treatment of osteoporosis and related bone disorders, as well as novel vitamin d3-derivatives
WO2003013577A3 (en) Use of il-18 inhibitors in hypersensitivity disorders
AU2002221509A1 (en) An chinese medicinal formulation treating stomachache, rib-side pain, headache and menstrual pain
WO2003096877A3 (en) Prevention and treatment of streptococcal and staphylococcal infection

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP